Navigation Links
Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
Date:5/26/2009

s a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

    CONTACT:  Paul Donovan
              508-650-8541 (office)
              508-667-5165 (mobile)
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696 (office)
              Investor Relations
              Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
2. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
3. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
4. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
5. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
6. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
7. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
8. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
9. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
10. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
11. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... NEWPORT NEWS, Virginia , 11. ... führender Hersteller von Kameras für die ... Brust (MBI/BSGI), hat heute die CE-Zulassung ... Mit dem CE-Zeichen kann Dilon das ... seinen Vertriebsbereich auf den Großteil der ...
(Date:7/10/2014)... Yesterday, former Congressman Patrick Kennedy ... facility. Rep. Kennedy and Dick Moberg ... research in neurological disease and treatment. ... Garen Staglin , created One Mind, a ... that will radically accelerate the development and implementation ...
(Date:7/10/2014)... , July 10, 2014   LabStyle ... Management Solution, today announced the appointment of Professor ... member of its Board of Directors. ... and business experience to LabStyle as an entrepreneur, ... legal and corporate governance expert. He currently serves ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... Feb. 22, 2011 Reportlinker.com announces that a ... catalogue: Global Pharmaceutical Contract Manufacturing ... This report analyzes the worldwide markets for ... following Dosage Forms: Injectables (Injections, Vials, and IV ...
... MedTrust Online (MedTrust) and Avantra Biosciences (Avantra) ... in the earliest stages of molecular diagnostic assay ... system. The two companies will ... care professionals with early access to the latest ...
Cached Medicine Technology:Reportlinker Adds Global Pharmaceutical Contract Manufacturing Industry 2Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care 2Avantra Biosciences and MedTrust Online Partner to Develop Clinically Important Protein Biomarker Assays for Improving Cancer Care 3
(Date:7/13/2014)... 2014 Epidemiologists forecast an increase in ... from 8,062 diagnosed incident cases in 2013 to 11,568 ... Rate (AGR) of 4.35%, during the forecast period. In ... diagnosed incident cases of aGVHD in the 6MM, with ... lowest number of diagnosed incident cases of aGVHD, with ...
(Date:7/13/2014)... ability to identify odors might indicate the development ... of the eye could indicate the build-up of ... brain, according to the results of four research ... Conference 2014 (AAIC 2014) in Copenhagen. , In ... identify odors was significantly associated with loss of ...
(Date:7/13/2014)... Wright & Schulte LLC has learned that ... July of 2015, in U.S. District Court, District of ... discovery process in the South Carolina federal court ... the multidistrict litigation (MDL). The complaints pending in the ... allege that they took the statin medication to lower ...
(Date:7/13/2014)... Celebrity fitness trainer and former World ... partnership with Aqua Health Labs for their flagship product ... . The collaboration was recently announced live on ESPN ... , actor, model, and a two time World Super ... he has prepared stars including Demi Moore, Hilary Swank ...
(Date:7/13/2014)... Hope Palliative & Hospice Care announced today that ... the Tamarack Senior Living Community in Palatine, IL. The group, ... the 3rd Wednesdays of every month. This group will ... located at 55 S. Greeley St. Palatine, IL 60067. ... no cost for the group. , “A grief support ...
Breaking Medicine News(10 mins):Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2
... By Mary Brophy Marcus HealthDay Reporter ... that,s typically used to treat the flu and Parkinson,s ... patients, a new study indicates. Traumatic brain injury ... to rehabilitation facilities after hospitalization were given amantadine hydrochloride. ...
... but long ago shelved after newer, modern antiretroviral therapies became ... uses its natural immunity to fight the viruswork that could ... published online this month by the journal PNAS , ... at the University of California, San Francisco (UCSF) presented the ...
... Feb. 29 (HealthDay News) -- Sports-related concussions are common in ... type of head injury, according to an expert. While ... immediate CT scan or MRI, concussion damage occurs at the ... scans of the brain, said Dr. Howard Derman, director of ...
... 29, 2012 - Scientists at the Toronto Western Research ... that protects the brain against the damaging effects of ... been in development for a few years. At this ... development among drugs created to reduce the brain,s vulnerability ...
... Scientists have combined two new "designer" forms of aspirin into ... its forebears in controlling the growth of several forms of ... so named because it releases nitric oxide (NO) and hydrogen ... Medicinal Chemistry Letters . Khosrow Kashfi, Ravinder Kodela and ...
... WEDNESDAY, Feb. 29 (HealthDay News) -- People worried about ... their life and their work performance, and their commitment ... questionnaires completed by 321 workers with an average age ... commercial distribution companies, or were temporary work agency employees. ...
Cached Medicine News:Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 2Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 3Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 4Health News:Old drug reveals new tricks 2Health News:Old drug reveals new tricks 3Health News:Sports Concussion: Myths and Facts 2Health News:Canadian scientist develops world's most advanced drug to protect the brain after a stroke 2
B-Hemoglobin test system provide quick, simple and reliable quantitative hemoglobin results. It has unbreakable, disposable cuvette which collect the exact amount of blood and mixes the sample with t...
... Variant hemoglobin testing system ... testing for diabetes monitoring, ... testing, hemoglobinopathy screening and ... single test. It has ...
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
... LH 755 simplifies and automates ... expert automation and advanced technologies ... reliable, accurate results every time. ... slide quality with its slide-on-slide ...
Medicine Products: